Making our mark on Amyotrophic Lateral Sclerosis (ALS)

Date posted: June 28, 2023


May was Amyotrophic Lateral Sclerosis (ALS) Awareness Month. ALS is a progressive disease that affects a person’s nerve cells in the brain and spinal cord, gradually weakening their muscles and resulting in an inability to walk, talk, eat, and eventually breathe. The prevalence of the rare disorder is six cases per 100,000 people*. 90% of cases occur without any known family history or genetic cause, according to the ALS Association. There is no cure yet.

Frontier Therapies has the privilege to serve people, caregivers and families living with ALS. Last month, our employees joined the fight against ALS by participating in the #InkedforALS campaign. 

Jess Stanton, Associate Director of Client Strategy at Frontier Therapies, shared why she supports the #InkedforALS campaign, “I not only want to drive awareness of ALS, I also want to amplify the need to improve access to medical care, and create a more inclusive, supportive society for people living with rare disease. At Frontier Therapies, we take the time to listen to our patients’ unique health care journeys and challenges. By understanding what our patients’ needs are, we can collaborate with the family and care team to design a personalized plan that helps everyone feel seen, heard and empowered.” 

The #InkedforALS initiative aligns with our commitment to helping patients and families living with rare disease get the therapy, care, and resources they need. To learn more about ALS and how you can show your support, please visit www.inkedforals.com.



*Accessed 6.28.2023.